Ionis pioneers RNA-based medicines.
Ionis Pharmaceuticals, Inc. (IONS) is expected to report earnings on Wednesday, November 4, 2026, before the open. Estimated release time 07:18 ET. Consensus EPS estimate is $-1.21.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-07-29 | Jun 2026 qtr | $-1.08 | $-0.69 | — | $267.95M |
| 2026-04-29 | Mar 2026 qtr | $-0.85 | $-0.30 | — | $246.09M |
| 2026-02-26 | Dec 2025 qtr | $-1.24 | $-1.41 | -14.0% | $203.00M |
| 2025-10-29 | Sep 2025 qtr | $-1.15 | $-0.61 | — | $156.72M |
| 2025-07-30 | Jun 2025 qtr | $0.27 | $0.78 | — | — |
| 2025-04-30 | Mar 2025 qtr | $-1.11 | $-0.93 | — | $131.61M |
| 2025-02-19 | Dec 2024 qtr | $-1.09 | $-0.66 | — | $226.58M |
| 2024-11-06 | Sep 2024 qtr | $-1.16 | $-0.95 | — | $133.81M |
IONS has beaten consensus EPS in 0 of its last 1 scored quarters.
See IONS on the live calendar →